InvestorsHub Logo
Followers 12
Posts 1138
Boards Moderated 0
Alias Born 12/22/2017

Re: techxen post# 12743

Saturday, 08/04/2018 8:40:10 PM

Saturday, August 04, 2018 8:40:10 PM

Post# of 27410
Thank YOU for taking the time and effort to focus on the fundamentals and avoid the commentary on short term price action and which will look silly in hindsight 3-5 years from now when this company has a $600-900 million market cap BEFORE the acquisition offer. The comments from Dr. Chan , several of the German doctor doctors and researchers about the products used beyond sepsis offer the chance for exceptional value creation over next 36-50 months. IMHO

Patented range of blood purification solutions in a recurring revenue “disposable razor blade “ offering 80% product margins + global 80 country market + real solutions “with no downside “ , growing acceptance as a standard of care+ US Navy support + US Army support + DARPA support +already several off label successes beyond sepsis + 2019 cancer cases plus FDA progress suggest 2019 could attract institutional investor interest and see the stock over $25.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News